Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GATS | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | MADD | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | NRSN1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-06 |
mRNA | CCDC102A | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | TSHZ1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | NAIP | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | LAIR1 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | PDE1A | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | ZNF532 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | ZNF43 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |